Clinical Trials Browser

Phase 2 Study × Gemcitabine × 90 days × Clear all

NCT07283705 2026-03-18

A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer

Phase 2 Suspended

Gastrointestinal

Phase 2 Study